Evolving Treatment Approaches to NMOSD: Clinical and Managed Care Perspectives
An AMCP webinar sponsored by Prime Education.
Neuromyelitis optica spectrum disorder (NMOSD) is a rare neurodegenerative disease characterized by attacks of inflammation of the optic nerve and spinal cord. Delays in treatment initiation and difficulties determining appropriate initial treatment selection, escalation, or switching, contribute to the challenges managing this disease. Several recently approved novel targeted therapies are poised to improve NMOSD management and clinical outcomes for patients. Join this webinar as NMOSD experts and managed care decision-makers discuss strategies for:
- Integrating the latest clinical data for recently approved therapies into treatment decision-making
- Assessing treatment response and applying current evidence on therapy escalation and/or switching
- Supporting NMOSD patient care through enhanced payer-provider collaboration
Sponsored by:
Prime Education
Register today for this live, 1-hour CME/CE webinar!
For individuals from the media/press who are interested in attending, please email media@amcp.org.
